Refine by
Blood Draw Articles & Analysis
72 news found
Last year, during Black History Month, our team at MedSource Labs took a closer look at the world of medical illustration and the ongoing efforts to address the lack of diversity in the field. We were inspired by the work of medical illustrators who are breaking barriers and ensuring that healthcare visuals represent the full spectrum of patients they serve. To see video, please click here What ...
” “This approach integrates the analysis of CTCs and cfDNA, enabling a multi-omic liquid biopsy from a single, minimally invasive blood draw. The possibility to integrate molecular and cellular residual disease in a single test might impact the sensitivity for the detection of residual disease after surgery,” says Dr. ...
The testing works by isolating cell-free DNA (cfDNA) from blood plasma to uncover circulating tumor DNA (ctDNA). Isolating these DNA samples from a simple blood draw is less invasive than a traditional biopsy, helping to simplify patient monitoring and more quickly guide clinical decision-making. ...
Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. ...
The iGEM (International Genetically Engineered Machine) Competition is an annual event in synthetic biology. Teams participating in iGEM typically spend several months conducting research, designing their projects, and building their biological systems. These projects can range from addressing real-world problems in areas such as healthcare, environmental sustainability, and manufacturing, to ...
Biotech and genomics companies Longenesis and Dante Genomics launch more personalised genomic services to more than 10,000 people across the Baltics and Italy, thus expanding and bridging the reach of valuable health insight delivery to patients across Europe. Latvian Biotechnology startup Longenesis has partnered with Dante Genomics, a global company of genomics and precision medicine, to offer ...
For many families, November signals the start of the holiday season. It is a special time to gather with loved ones and check-in to make sure everyone is happy and healthy. November is also lung cancer awareness month. VisionGate wants to help you, your family and loved ones learn more about who is at risk, the impact, and the types of lung cancer. Because keeping yourself informed ...
Rarecells leverages its proprietary ISET® Circulating Tumor Cells (CTC) platform, combined with cutting-edge downstream analyses, to generate a novel and powerful approach to detect evidence of a tumor from a blood sample. By applying advanced AI algorithms to immunomorphological cellular profiles and altered genome-wide DNA characteristics, the company is developing a new ...
The marker-independent ISET technology has already been shown to detect CTC from NSCLC with unparalleled sensitivity and specificity, prior to imaging. However, CTC rarity in usual blood draw volumes can prevent extensive CTC analyses and culture. Diagnostic leukapheresis (DLA) is a robust process that concentrates mononuclear cells, including CTC, from the ...
Why should payers care about clinical laboratory testing? Clinical laboratory testing plays an essential role in the delivery of health care. From early detection and diagnosis of disease to individualized treatment plans based on a person’s unique biology, medical care depends on accurate and timely health data. Seventy percent of medical decisions depend on lab test results, so making ...
Babson Diagnostics, a science-first health care technology company, today announced that it continues to grow its management team with the addition of four key leaders. The new team members bring skill sets and experience that will support the commercial launch of its blood testing ecosystem, which reimagines blood testing from collection to sample preparation to analysis, to better meet the ...
IRVINE, Calif. – AUG. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and Phase 2 clinical trials investigating its anti-SARS-CoV-2 vaccine candidate AV-COVID-19 that is made at point-of-care by third-party personnel. The results were published in the article ...
(Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, today announced that the first blood-based cancer testing services in Europe based on Guardant Health’s industry-leading digital sequencing platform are now available at the VHIO liquid biopsy testing ...
Since 2019, the two companies have collaborated to create a capillary blood collection and testing system, now in advanced development, to enable laboratory-quality, small-volume capillary blood collection at retail settings by team members with no previous experience in blood collection. ...
Highly sensitive Shield test offers convenient screening method that can be completed with simple blood draw, helping overcome barriers to compliance Test demonstrated sensitivity of 91% in colorectal cancer and 20% in advanced adenoma detection with specificity of 92% in validation studies PALO ALTO, ...
Significant reduction in sample size helps your lab focus on testing, not sample management NOVEOS not only runs more allergy tests and more follow-up tests per tube, it also reduces additional blood draws. The small sample volume also reduces the need for test prioritization by clinicians and laboratorians. ...
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Edwin “Ed” E. Rule, has joined the Company as Vice President Regulatory, Quality and Compliance. He will report ...
” The Cytovale system directly analyzes white blood cells using rapid techniques that look at cell structure, making it a faster and less expensive diagnostic compared to gene expression diagnostic systems. Cytovale’s IntelliSep test uses a biomechanical evaluation of white blood cells from a standard blood draw, ...
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now being sold into accounts using Kurin. “We are proud to commercialize the Advance Safety Needle, as there ...
Importantly, the President’s plan recognizes that the rigorous study of multi-cancer detection blood tests, to date, has brought us to a crucial inflection point where detecting many cancers at once is now an essential pillar of any effort to end cancer as we know it ...